Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 3Phase NA 2Phase 1 2Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 11INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4Neoplasms 3Rectal Neoplasms 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Leukemia, Myeloid, Acute 2Carcinoma, Hepatocellular 2Weight Loss 1Warts 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteosarcoma 1Oesophagogastric Cancer 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lung Neoplasms 1Leukopenia 1Leukemia, Promyelocytic, Acute 1Leukemia, Biphenotypic, Acute 1Insulin Resistance 1Infertility 1Immunotherapy Gastrict Cancer 1Hydatidiform Mole 1Glioma 1

Interventions

anlotinib 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER_GOV × Esophageal Squamous Cell Carcinoma × Clear all
NCT06354530 2024-04-09

A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

Army Medical Center of PLA

Phase 2/3 Recruiting
266 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡